NASDAQ:AGTC

Applied Genetic Technologies Corporation Earning Date

USA |NASDAQ |USD

AGTC Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 15, 2021 Sep 2021 $-0.35 $-0.28 $-0.60
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 15, 2021 Sep 2021 $80.00K $500.00K $0.00

Applied Genetic Technologies Corporation's next earnings date is Monday, Nov 15, 2021 for the fiscal quarter ending Sep 2021.

AGTC Earnings Date & History Chart

AGTC Earnings & Revenue Forecast

AGTC Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 7 $-0.36 $-0.41 $-0.32
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Jun 2022 9 $-1.40 $-1.74 $-1.18
Jun 2023 9 $-1.37 $-1.66 $-0.92

AGTC Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 4 / 0 $-0.41 $-0.41 $-0.42
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Jun 2022 7 / 0 $-1.64 $-1.64 $-1.61
Jun 2023 4 / 0 $-1.33 $-1.33 $-1.33

AGTC Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 6 $80.00K $0.00 $500.00K
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Jun 2022 7 $290.00K $0.00 $2.00M
Jun 2023 8 $4.56M $0.00 $19.09M

AGTC Earnings Date & Revenue History

AGTC Earnings History

|
Show More
Show More

AGTC Revenue History

|
Show More
Show More

Applied Genetic Technologies Corporation Next Earnings Date & Report

AGTC Next Earnings Date & Report Preview: Sep 2021 (FQ)

AGTC's next earnings date is Monday, Nov 15, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 7 analysts, the average EPS estimation for Applied Genetic Technologies Corporation's next quarterly earnings is $-0.35, with a low EPS estimation of $-0.39, and a high estimation of $-0.32.

Over the last 1 month, EPS estimates have seen 4 upward revisions and 0 downward. The EPS 1 month trend is $-0.41, the last 2 month trend is $-0.41, and the 3 month trend is $-0.42.

Based on 5 analysts, the average revenue estimation is $80.00K, with a low revenue estimation of $0.00, and a high estimation of $500.00K.

Applied Genetic Technologies Corporation Previous Earnings Dates & Reports

AGTC Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Applied Genetic Technologies Corporation's previous earnings date was Sep 23, 2021 for its fiscal quarter ended Jun 30, 2021.

AGTC's earnings per share (EPS) was $-0.28, beating the consensus analysts forecast of $-0.37 by 24.91%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by -30.00%, and higher than the same period a year before (Jun 2020) by -50.00%.

Revenues were $500.00K.

The company reported a net income of $-12.14M.

Free cash flow for the quarter was $-13.95M , compared to $-11.80M last quarter and $-13.80M a year before.

AGTC ended the quarter with $24.48M in total debt, an increase of 67.76% compared to the previous quarter, and an increase of 127.02% compared to the same quarter a year before.

AGTC Previous Earnings Date & Report Recap: Jun 2021 (FY)

Applied Genetic Technologies Corporation's previous annual earnings date was Sep 23, 2021 for its fiscal year ended Jun 30, 2021.

AGTC's earnings per share (EPS) was $-1.88, beating the consensus analysts forecast of $-1.91 by -1.57% , and higher than the previous year's EPS (Jun 2020) by -13.36%.

Revenues were $500.00K.

The company reported a net income of $-57.83M.

Applied Genetic Technologies Corporation reported a free cash flow of $-53.03M for its fiscal year, compared to $-42.82M a year ago.

The company ended the fiscal year with $24.48M in total debt, an increase of 127.02% compared to the previous year.